Â¥
9.61
Nov 29
New Key Statistics Module, Z-Score and F-Score
SZSE:300534 Key Ratios
Market Cap ¥ M | 2,915.14 |
Enterprise Value ¥ M | 2,707.94 |
P/E(ttm) | 73.36 |
PE Ratio without NRI | 72.26 |
Forward PE Ratio | -- |
Price/Book | 4.51 |
Price/Sales | 2.74 |
Price/Free Cash Flow | 20.97 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.30 |
Revenue (TTM) ¥ M | 1,073.00 |
EPS (TTM) ¥ | 0.13 |
Beneish M-Score | -3.37 |
10-y EBITDA Growth Rate % | -4.10 |
5-y EBITDA Growth Rate % | 30.20 |
y-y EBITDA Growth Rate % | -19.10 |
EV-to-EBIT | 27.66 |
EV-to-EBITDA | 27.66 |
PEG | 2.39 |
Shares Outstanding M | 303.35 |
Net Margin (%) | 3.69 |
Operating Margin % | 8.44 |
Pre-tax Margin (%) | 8.70 |
Quick Ratio | 1.08 |
Current Ratio | 1.29 |
ROA % (ttm) | 2.90 |
ROE % (ttm) | 6.18 |
ROIC % (ttm) | 8.93 |
Dividend Yield % | 0.42 |
Altman Z-Score | 3.96 |
SZSE:300534 Number of Guru Trades
SZSE:300534 Volume of Guru Trades
Gurus Latest Trades with SZSE:300534
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300534 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Insider Transactions
No Available Data